# TECHNICAL ADVISORY BOARD AGREEMENT

---

**AGENTIC LABORATORY**
Mount Sinai West Hospital
Mount Sinai Health System

---

This Technical Advisory Board Agreement ("Agreement") is entered into as of **[EFFECTIVE DATE]** ("Effective Date") by and between:

**The Agentic Laboratory**, a division of Mount Sinai West Hospital, part of the Icahn School of Medicine at Mount Sinai / Mount Sinai Health System, with offices at 1000 Tenth Avenue, New York, NY 10019 (the "Company" or "Lab"),

and

**[ADVISOR FULL NAME]**, an individual with a principal address at [ADVISOR ADDRESS] (the "Advisor").

The Company and the Advisor are each referred to herein as a "Party" and collectively as the "Parties."

---

## RECITALS

**WHEREAS**, the Company operates the Agentic Laboratory, which develops production-grade healthcare software using multi-agent AI systems and clinician-led development methodologies;

**WHEREAS**, the Company desires to establish a Technical Advisory Board to provide strategic guidance on technology architecture, agentic coding practices, healthcare AI governance, and related matters;

**WHEREAS**, the Advisor possesses expertise in [AREA OF EXPERTISE] and has been identified by the Company as a qualified candidate to serve on the Technical Advisory Board; and

**WHEREAS**, the Advisor desires to provide advisory services to the Company on the terms set forth herein;

**NOW, THEREFORE**, in consideration of the mutual covenants and agreements contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:

---

## 1. ADVISORY SERVICES

### 1.1 Scope of Services

The Advisor agrees to provide the following services to the Company (collectively, the "Services"):

**(a) Quarterly Advisory Meetings.** Attend and actively participate in four (4) quarterly advisory board meetings per year, each approximately two (2) hours in duration. Meetings will be held via video conference unless otherwise agreed, with one optional in-person meeting per year at the Company's New York City offices.

**(b) Strategic Counsel.** Provide strategic advice and guidance on the following areas:

- Technology stack selection, evaluation, and architecture decisions
- Multi-agent AI development strategy, including orchestration frameworks, model selection, and prompt engineering methodologies
- High-level project portfolio review and architectural oversight
- Healthcare AI governance, including HIPAA compliance, responsible AI deployment, bias monitoring, and patient safety considerations
- Agentic coding best practices, human-in-the-loop workflows, and the evolving landscape of AI-assisted software development
- Growth strategy, partnerships, research collaborations, and talent acquisition

**(c) Between-Meeting Consultation.** Make themselves reasonably available between quarterly meetings for email correspondence, brief telephone or video consultations, and review of materials as reasonably requested by the Company, estimated at approximately three (3) to five (5) hours per quarter.

**(d) Ad Hoc Requests.** Provide input on specific technical questions, review architectural proposals or whitepapers, and offer introductions to relevant contacts in the Advisor's professional network, as reasonably requested.

### 1.2 Standard of Performance

The Advisor shall perform the Services in a professional manner consistent with the highest standards of the Advisor's profession and in accordance with all applicable laws and regulations.

### 1.3 Time Commitment

The total expected time commitment is approximately twelve (12) to fifteen (15) hours per quarter. The Advisor acknowledges that this commitment is an estimate and that actual time may vary. The Company agrees not to request time commitments that substantially exceed this estimate without the Advisor's consent.

### 1.4 No Management Authority

The Advisor's role is advisory in nature. The Advisor shall have no authority to bind the Company, make decisions on behalf of the Company, or direct the activities of Company personnel. Recommendations made by the Advisor or the Advisory Board are non-binding and provided for the Company's consideration only.

---

## 2. TERM AND TERMINATION

### 2.1 Initial Term

This Agreement shall commence on the Effective Date and continue for a period of one (1) year (the "Initial Term"), unless earlier terminated in accordance with this Section 2.

### 2.2 Renewal

Upon expiration of the Initial Term, this Agreement shall automatically renew for successive one (1) year periods (each a "Renewal Term," and together with the Initial Term, the "Term"), unless either Party provides written notice of non-renewal at least thirty (30) days prior to the expiration of the then-current Term.

### 2.3 Termination Without Cause

Either Party may terminate this Agreement at any time, for any reason or no reason, upon thirty (30) days' prior written notice to the other Party.

### 2.4 Termination for Cause

Either Party may terminate this Agreement immediately upon written notice if the other Party:

(a) Materially breaches any provision of this Agreement and fails to cure such breach within fifteen (15) days after receiving written notice thereof;

(b) Engages in conduct that is materially detrimental to the other Party's reputation or interests;

(c) Is convicted of, or pleads guilty or no contest to, a felony or any crime involving moral turpitude, fraud, or dishonesty; or

(d) Becomes unable to perform the Services due to death, disability, or incapacity.

### 2.5 Effect of Termination

Upon termination or expiration of this Agreement:

(a) The Advisor shall cease performing the Services and shall no longer represent themselves as an advisor to the Company;

(b) The Company shall pay the Advisor any earned but unpaid compensation through the effective date of termination, prorated for any partial quarter;

(c) The Advisor shall promptly return or destroy all Proprietary Information (as defined in Section 4) in their possession or control; and

(d) The provisions of Sections 4 (Confidentiality), 5 (Intellectual Property), 6 (Non-Solicitation), 8 (Indemnification), 9 (Limitation of Liability), and 11 (General Provisions) shall survive termination.

---

## 3. COMPENSATION AND EXPENSES

### 3.1 Advisory Retainer

In consideration of the Services, the Company shall pay the Advisor a quarterly retainer of **$[QUARTERLY AMOUNT]** (the "Retainer"), payable within fifteen (15) days of the beginning of each calendar quarter during the Term.

### 3.2 Proration

If this Agreement commences or terminates on a date other than the first or last day of a calendar quarter, the Retainer for that quarter shall be prorated based on the number of days in the quarter during which this Agreement was in effect.

### 3.3 Expense Reimbursement

The Company shall reimburse the Advisor for reasonable, pre-approved, out-of-pocket expenses incurred in connection with the performance of the Services, including travel expenses for any in-person meetings. The Advisor shall submit expense reports with supporting documentation within thirty (30) days of incurring the expense. Reimbursement shall be made within thirty (30) days of the Company's receipt of a properly documented expense report.

### 3.4 Taxes

The Advisor is solely responsible for all taxes, social security contributions, and other withholdings related to the compensation received under this Agreement. The Company will issue an IRS Form 1099 (or equivalent) to the Advisor as required by law.

### 3.5 No Additional Compensation

Except as expressly set forth in this Section 3, the Advisor shall not be entitled to any other compensation, benefits, or perquisites from the Company.

---

## 4. CONFIDENTIALITY

### 4.1 Definition of Proprietary Information

"Proprietary Information" means any and all information, whether written, oral, electronic, visual, or in any other form, that is disclosed by or on behalf of the Company to the Advisor, or that the Advisor obtains or develops in connection with the Services, including but not limited to:

(a) Trade secrets, inventions, ideas, processes, formulas, algorithms, source code, object code, software, data, datasets, and know-how;

(b) Business plans, strategies, financial information, projections, budgets, and pricing;

(c) Patient data, clinical information, health records, and any information subject to the Health Insurance Portability and Accountability Act of 1996 ("HIPAA") or any other healthcare privacy law or regulation;

(d) Product plans, designs, roadmaps, technical specifications, and architecture documentation;

(e) Customer, partner, and vendor lists, relationships, and related information;

(f) Research, experimental work, and results;

(g) Personnel information, compensation data, and organizational plans; and

(h) Any other information that is designated as confidential or that a reasonable person would understand to be confidential given the nature of the information and the circumstances of disclosure.

Proprietary Information does not include information that: (i) is or becomes publicly available through no fault of the Advisor; (ii) was known to the Advisor prior to disclosure by the Company, as demonstrated by written records; (iii) is independently developed by the Advisor without reference to or use of the Proprietary Information; or (iv) is rightfully received by the Advisor from a third party without restriction on disclosure.

### 4.2 Obligations

The Advisor agrees to:

(a) Hold all Proprietary Information in strict confidence;

(b) Not disclose, publish, or otherwise disseminate Proprietary Information to any third party without the prior written consent of the Company;

(c) Use Proprietary Information solely for the purpose of performing the Services under this Agreement;

(d) Take all reasonable precautions to prevent unauthorized access to or disclosure of Proprietary Information, using at least the same degree of care the Advisor uses to protect their own confidential information, but in no event less than reasonable care;

(e) Immediately notify the Company in writing of any unauthorized use or disclosure of Proprietary Information of which the Advisor becomes aware; and

(f) Not remove any proprietary, copyright, trade secret, or other legend from any materials provided by the Company.

### 4.3 Compelled Disclosure

If the Advisor is compelled by law, regulation, legal process, or governmental order to disclose Proprietary Information, the Advisor shall: (a) provide the Company with prompt written notice of such requirement (to the extent legally permitted); (b) cooperate with the Company, at the Company's expense, in seeking a protective order or other appropriate remedy; and (c) disclose only that portion of the Proprietary Information that is legally required to be disclosed.

### 4.4 Return of Materials

Upon termination or expiration of this Agreement, or upon the Company's request at any time, the Advisor shall promptly return or destroy all materials (whether physical or electronic) containing Proprietary Information and certify in writing that all such materials have been returned or destroyed.

### 4.5 HIPAA Compliance

The Advisor acknowledges that certain Proprietary Information may constitute Protected Health Information ("PHI") as defined under HIPAA. The Advisor agrees to comply with all applicable provisions of HIPAA and any related regulations with respect to any PHI to which the Advisor may have access. If necessary, the Parties shall enter into a separate Business Associate Agreement ("BAA") as required under HIPAA.

### 4.6 Survival

The obligations under this Section 4 shall survive the termination or expiration of this Agreement for a period of three (3) years, except with respect to trade secrets, which shall be protected for as long as they maintain their trade secret status under applicable law.

---

## 5. INTELLECTUAL PROPERTY

### 5.1 Assignment of Work Product

The Advisor agrees that all work product created, conceived, developed, or reduced to practice by the Advisor, solely or jointly with others, in connection with the performance of the Services (collectively, "Work Product") shall be the sole and exclusive property of the Company. Work Product includes, without limitation, all inventions, discoveries, improvements, ideas, concepts, designs, writings, presentations, reports, analyses, recommendations, code, documentation, data compilations, and any other materials, whether or not patentable or copyrightable.

### 5.2 Work Made for Hire

To the extent that any Work Product constitutes a "work made for hire" as defined under the United States Copyright Act (17 U.S.C. Section 101), such Work Product shall be deemed a work made for hire and the Company shall be deemed the author thereof.

### 5.3 Assignment

To the extent that any Work Product does not qualify as a work made for hire, the Advisor hereby irrevocably assigns to the Company all right, title, and interest in and to such Work Product, including all patent rights, copyrights, trade secret rights, and other intellectual property rights therein.

### 5.4 Further Assurances

The Advisor agrees to execute, at the Company's expense, all documents and take all actions reasonably requested by the Company to perfect, register, or enforce the Company's rights in the Work Product.

### 5.5 Pre-Existing Intellectual Property

Nothing in this Agreement shall be construed to transfer to the Company any intellectual property owned by the Advisor prior to the Effective Date or developed by the Advisor outside the scope of the Services ("Advisor IP"). If the Advisor incorporates any Advisor IP into Work Product, the Advisor hereby grants the Company a non-exclusive, royalty-free, perpetual, irrevocable, worldwide license to use, modify, and distribute such Advisor IP as part of the Work Product.

### 5.6 General Knowledge

Nothing in this Section 5 shall prevent the Advisor from using general knowledge, skills, and experience acquired during the performance of the Services, provided that such use does not violate the confidentiality obligations in Section 4.

---

## 6. NON-SOLICITATION

### 6.1 Non-Solicitation of Employees

During the Term and for a period of twelve (12) months following termination or expiration of this Agreement, the Advisor shall not, directly or indirectly, solicit, recruit, or induce any employee or contractor of the Company to leave the Company's employ or service, or hire any such individual, without the prior written consent of the Company.

### 6.2 Non-Solicitation of Clients

During the Term and for a period of twelve (12) months following termination or expiration of this Agreement, the Advisor shall not, directly or indirectly, solicit or induce any client, customer, or partner of the Company to terminate or reduce their relationship with the Company.

---

## 7. CONFLICT OF INTEREST

### 7.1 Disclosure

The Advisor shall promptly disclose to the Company any existing or potential conflicts of interest that could reasonably affect the Advisor's ability to perform the Services objectively, including without limitation:

(a) Current or anticipated advisory, consulting, employment, or board positions with any entity that competes with, or could reasonably be expected to compete with, the Company;

(b) Financial interests in any entity with which the Company does business or is considering doing business; and

(c) Any other circumstance that could create an actual or apparent conflict of interest.

### 7.2 Ongoing Obligation

The obligation to disclose conflicts of interest is ongoing throughout the Term. The Advisor shall promptly notify the Company if any new conflict or potential conflict arises.

### 7.3 Company's Rights

Upon disclosure of a conflict, the Company may, at its sole discretion: (a) waive the conflict in writing; (b) modify the scope of the Advisor's Services to mitigate the conflict; or (c) terminate this Agreement in accordance with Section 2.

---

## 8. INDEMNIFICATION

### 8.1 Advisor Indemnification

The Advisor shall indemnify, defend, and hold harmless the Company and its officers, directors, employees, agents, and affiliates from and against any and all claims, damages, losses, liabilities, costs, and expenses (including reasonable attorneys' fees) arising out of or related to: (a) the Advisor's breach of this Agreement; (b) the Advisor's negligence or willful misconduct in the performance of the Services; or (c) any claim that the Advisor's work product infringes the intellectual property rights of a third party.

### 8.2 Company Indemnification

The Company shall indemnify, defend, and hold harmless the Advisor from and against any and all claims, damages, losses, liabilities, costs, and expenses (including reasonable attorneys' fees) arising out of or related to: (a) the Company's breach of this Agreement; (b) the Company's use of the Services or Work Product, except to the extent caused by the Advisor's breach, negligence, or willful misconduct; or (c) the Company's negligence or willful misconduct.

---

## 9. LIMITATION OF LIABILITY

### 9.1 No Consequential Damages

IN NO EVENT SHALL EITHER PARTY BE LIABLE TO THE OTHER FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR PUNITIVE DAMAGES ARISING OUT OF OR RELATED TO THIS AGREEMENT, REGARDLESS OF THE THEORY OF LIABILITY, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.

### 9.2 Cap on Liability

EXCEPT FOR BREACHES OF SECTION 4 (CONFIDENTIALITY) OR SECTION 5 (INTELLECTUAL PROPERTY), THE TOTAL AGGREGATE LIABILITY OF EITHER PARTY UNDER THIS AGREEMENT SHALL NOT EXCEED THE TOTAL COMPENSATION PAID OR PAYABLE TO THE ADVISOR DURING THE TWELVE (12) MONTH PERIOD PRECEDING THE EVENT GIVING RISE TO THE CLAIM.

---

## 10. INDEPENDENT CONTRACTOR

### 10.1 Status

The Advisor is an independent contractor and not an employee, agent, partner, or joint venturer of the Company. Nothing in this Agreement shall be construed to create an employment relationship, partnership, joint venture, or agency relationship between the Parties.

### 10.2 No Benefits

The Advisor is not entitled to any employee benefits from the Company, including but not limited to health insurance, retirement benefits, workers' compensation, unemployment insurance, paid time off, or any other benefits.

### 10.3 No Authority to Bind

The Advisor shall not have the authority to bind the Company to any agreement, obligation, or commitment, or to represent themselves as having such authority, without the express prior written consent of the Company.

### 10.4 Advisor's Responsibilities

The Advisor is responsible for providing their own workspace, equipment, and tools necessary to perform the Services, unless otherwise agreed in writing.

---

## 11. GENERAL PROVISIONS

### 11.1 Governing Law

This Agreement shall be governed by and construed in accordance with the laws of the State of New York, without regard to its conflict of laws principles.

### 11.2 Dispute Resolution

Any dispute arising out of or relating to this Agreement shall first be submitted to good-faith mediation. If mediation is unsuccessful, the dispute shall be resolved by binding arbitration in New York, New York, administered by the American Arbitration Association in accordance with its Commercial Arbitration Rules. The arbitrator's decision shall be final and binding, and judgment upon the award may be entered in any court of competent jurisdiction.

### 11.3 Entire Agreement

This Agreement constitutes the entire agreement between the Parties with respect to the subject matter hereof and supersedes all prior and contemporaneous agreements, negotiations, representations, and understandings, whether written or oral.

### 11.4 Amendments

This Agreement may not be amended or modified except by a written instrument signed by both Parties.

### 11.5 Waiver

The failure of either Party to enforce any provision of this Agreement shall not constitute a waiver of that Party's right to enforce that provision or any other provision in the future.

### 11.6 Severability

If any provision of this Agreement is held to be invalid, illegal, or unenforceable, the remaining provisions shall continue in full force and effect.

### 11.7 Assignment

The Advisor may not assign or transfer this Agreement or any rights or obligations hereunder without the prior written consent of the Company. The Company may assign this Agreement to any successor entity or affiliate without the Advisor's consent.

### 11.8 Notices

All notices required or permitted under this Agreement shall be in writing and shall be deemed given when: (a) delivered personally; (b) sent by email with confirmed receipt; or (c) sent by certified mail, return receipt requested, postage prepaid, to the addresses set forth above or to such other address as either Party may designate in writing.

### 11.9 Counterparts

This Agreement may be executed in counterparts, each of which shall be deemed an original and all of which together shall constitute one and the same instrument. Electronic signatures shall be deemed valid and binding.

### 11.10 Headings

The headings in this Agreement are for convenience only and shall not affect the interpretation of this Agreement.

---

## SIGNATURES

**IN WITNESS WHEREOF**, the Parties have executed this Agreement as of the Effective Date.

---

**AGENTIC LABORATORY / MOUNT SINAI WEST HOSPITAL**

| | |
|---|---|
| Signature: | ________________________________ |
| Name: | Dr. Jeff Bander |
| Title: | Director, Agentic Laboratory |
| Date: | ________________________________ |

---

**ADVISOR**

| | |
|---|---|
| Signature: | ________________________________ |
| Name: | [ADVISOR FULL NAME] |
| Title: | [ADVISOR TITLE] |
| Date: | ________________________________ |

---

## EXHIBIT A: ADVISORY BOARD CHARTER SUMMARY

### Purpose

The Technical Advisory Board provides non-binding strategic guidance to the Agentic Laboratory on matters of technology architecture, agentic AI development, healthcare software governance, and growth strategy.

### Composition

The Advisory Board shall consist of no more than six (6) members, each selected for their expertise in computer science, healthcare technology, AI/ML engineering, software architecture, or related disciplines.

### Meeting Cadence

| Meeting Type | Frequency | Duration | Format |
|---|---|---|---|
| Quarterly Strategic Review | 4x per year | ~2 hours | Video conference |
| Annual In-Person Session | 1x per year (optional) | Half day | New York City |
| Ad Hoc Consultations | As needed | ~30-60 min | Email / phone / video |

### Standing Agenda Items for Quarterly Meetings

1. **Lab Update** -- Director's report on projects, milestones, and key metrics
2. **Technology Review** -- Assessment of current technology stack, tools, and infrastructure
3. **Architecture Discussion** -- Review of major architectural decisions and proposals
4. **AI/ML Governance** -- Model performance, compliance, risk, and responsible AI updates
5. **Strategic Discussion** -- Open-format discussion on emerging opportunities, threats, and strategic direction
6. **Action Items** -- Summary of recommendations and next steps

### Advisory Focus Areas

| Domain | Key Questions |
|---|---|
| **Technology Stack** | Are we using the right tools? Where should we invest or divest? |
| **Agentic Coding** | How should multi-agent development workflows evolve? What best practices should we adopt? |
| **Architecture** | Are our systems scalable, secure, and maintainable? Where are the risks? |
| **Healthcare AI** | Are we deploying AI responsibly? Are we compliant with HIPAA and emerging AI regulations? |
| **Growth** | Where are the opportunities for partnerships, research grants, and expansion? |

### Decision-Making

The Advisory Board operates in a purely advisory capacity. All recommendations are non-binding. The Company retains sole authority over all business, technical, and operational decisions.

---

*End of Agreement*
